273 related articles for article (PubMed ID: 29158829)
1. Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX.
Lau J; Lin KS; Bénard F
Theranostics; 2017; 7(17):4322-4339. PubMed ID: 29158829
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
Pastorek J; Pastorekova S
Semin Cancer Biol; 2015 Apr; 31():52-64. PubMed ID: 25117006
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one.
Supuran CT; Alterio V; Di Fiore A; D' Ambrosio K; Carta F; Monti SM; De Simone G
Med Res Rev; 2018 Sep; 38(6):1799-1836. PubMed ID: 29635752
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
Thiry A; Dogné JM; Masereel B; Supuran CT
Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
[TBL] [Abstract][Full Text] [Related]
6. Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors.
Kalinin S; Malkova A; Sharonova T; Sharoyko V; Bunev A; Supuran CT; Krasavin M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948200
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in Vivo Biological Evaluation of (68)Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission Tomography.
Sneddon D; Niemans R; Bauwens M; Yaromina A; van Kuijk SJ; Lieuwes NG; Biemans R; Pooters I; Pellegrini PA; Lengkeek NA; Greguric I; Tonissen KF; Supuran CT; Lambin P; Dubois L; Poulsen SA
J Med Chem; 2016 Jul; 59(13):6431-43. PubMed ID: 27322137
[TBL] [Abstract][Full Text] [Related]
9. The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond.
Pastorekova S; Gillies RJ
Cancer Metastasis Rev; 2019 Jun; 38(1-2):65-77. PubMed ID: 31076951
[TBL] [Abstract][Full Text] [Related]
10. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.
Lawrentschuk N; Lee FT; Jones G; Rigopoulos A; Mountain A; O'Keefe G; Papenfuss AT; Bolton DM; Davis ID; Scott AM
Urol Oncol; 2011; 29(4):411-20. PubMed ID: 19523858
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase IX as a target for metastatic disease.
Gieling RG; Williams KJ
Bioorg Med Chem; 2013 Mar; 21(6):1470-6. PubMed ID: 23098607
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis-induced ectodomain shedding of hypoxia-regulated carbonic anhydrase IX from tumor cells: a double-edged response to chemotherapy.
Vidlickova I; Dequiedt F; Jelenska L; Sedlakova O; Pastorek M; Stuchlik S; Pastorek J; Zatovicova M; Pastorekova S
BMC Cancer; 2016 Mar; 16():239. PubMed ID: 26993100
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
Winum JY; Rami M; Scozzafava A; Montero JL; Supuran C
Med Res Rev; 2008 May; 28(3):445-63. PubMed ID: 17880011
[TBL] [Abstract][Full Text] [Related]
14. Disclosing the Interaction of Carbonic Anhydrase IX with Cullin-Associated NEDD8-Dissociated Protein 1 by Molecular Modeling and Integrated Binding Measurements.
Buonanno M; Langella E; Zambrano N; Succoio M; Sasso E; Alterio V; Di Fiore A; Sandomenico A; Supuran CT; Scaloni A; Monti SM; De Simone G
ACS Chem Biol; 2017 Jun; 12(6):1460-1465. PubMed ID: 28388044
[TBL] [Abstract][Full Text] [Related]
15. In Search of Advanced Tumor Diagnostics and Treatment: Achievements and Perspectives of Carbonic Anhydrase IX Targeted Delivery.
Janoniene A; Petrikaite V
Mol Pharm; 2020 Jun; 17(6):1800-1815. PubMed ID: 32374612
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Nonpeptidic Ligand Conjugates for the Treatment of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.
Lv PC; Roy J; Putt KS; Low PS
Mol Cancer Ther; 2017 Mar; 16(3):453-460. PubMed ID: 27980101
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
